278 related articles for article (PubMed ID: 7981441)
1. Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.
Bier B; Douglas-Jones A; Tötsch M; Dockhorn-Dworniczak B; Böcker W; Jasani B; Schmid KW
Breast Cancer Res Treat; 1994; 30(3):213-21. PubMed ID: 7981441
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
[TBL] [Abstract][Full Text] [Related]
4. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
5. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
Goldstein NS; O'Malley BA
Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
[TBL] [Abstract][Full Text] [Related]
6. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
7. Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast.
Schmid KW; Ellis IO; Gee JM; Darke BM; Lees WE; Kay J; Cryer A; Stark JM; Hittmair A; Ofner D
Virchows Arch A Pathol Anat Histopathol; 1993; 422(2):153-9. PubMed ID: 8385380
[TBL] [Abstract][Full Text] [Related]
8. Significance of metallothionein expression in breast myoepithelial cells.
Jin R; Bay BH; Chow VT; Tan PH; Dheen T
Cell Tissue Res; 2001 Feb; 303(2):221-6. PubMed ID: 11291768
[TBL] [Abstract][Full Text] [Related]
9. Quantitative histopathological variables in in situ and invasive ductal and lobular carcinomas of the breast.
Ladekarl M; Sørensen FB
APMIS; 1993 Dec; 101(12):895-903. PubMed ID: 8110444
[TBL] [Abstract][Full Text] [Related]
10. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
11. Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.
Reis-Filho JS; Steele D; Di Palma S; Jones RL; Savage K; James M; Milanezi F; Schmitt FC; Ashworth A
Mod Pathol; 2006 Feb; 19(2):307-19. PubMed ID: 16424897
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
14. Are epithelial cells in fat or connective tissue a reliable indicator of tumor invasion in fine-needle aspiration of the breast?
Maygarden SJ; Brock MS; Novotny DB
Diagn Cytopathol; 1997 Feb; 16(2):137-42. PubMed ID: 9067105
[TBL] [Abstract][Full Text] [Related]
15. Localization of metallothionein in breast carcinomas. An immunohistochemical study.
Fresno M; Wu W; Rodriguez JM; Nadji M
Virchows Arch A Pathol Anat Histopathol; 1993; 423(3):215-9. PubMed ID: 8236816
[TBL] [Abstract][Full Text] [Related]
16. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining with monoclonal Ab B72.3 in benign and malignant breast disease.
Tavassoli FA; Jones MW; Majeste RM; Bratthauer GL; O'Leary TJ
Am J Surg Pathol; 1990 Feb; 14(2):128-33. PubMed ID: 2301698
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ.
Böcker W; Bier B; Freytag G; Brömmelkamp B; Jarasch ED; Edel G; Dockhorn-Dworniczak B; Schmid KW
Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):323-30. PubMed ID: 1384227
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases.
Haerslev T; Jacobsen K; Nedergaard L; Zedeler K
Pathol Res Pract; 1994 Aug; 190(7):675-81. PubMed ID: 7808966
[TBL] [Abstract][Full Text] [Related]
20. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis.
O'Connell JT; Shao ZM; Drori E; Basbaum CB; Barsky SH
Hum Pathol; 1998 Dec; 29(12):1517-23. PubMed ID: 9865841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
